---
ver: rpa2
title: 'SpecReX: Explainable AI for Raman Spectroscopy'
arxiv_id: '2503.14567'
source_url: https://arxiv.org/abs/2503.14567
tags:
- specrex
- peak
- which
- raman
- features
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: This paper introduces SpecReX, a causal explainability algorithm
  for deep learning models trained on Raman spectroscopy data. The authors create
  three increasingly complex simulated Raman datasets with known ground truth signals
  to evaluate SpecReX against SHAP variants (KernelSHAP, GradientSHAP, DeepLIFTSHAP).
---

# SpecReX: Explainable AI for Raman Spectroscopy

## Quick Facts
- arXiv ID: 2503.14567
- Source URL: https://arxiv.org/abs/2503.14567
- Reference count: 18
- SpecReX outperforms SHAP variants at localizing spectral peaks in synthetic Raman datasets

## Executive Summary
SpecReX is a causal explainability algorithm designed for deep learning models trained on Raman spectroscopy data. The paper evaluates SpecReX against SHAP variants (KernelSHAP, GradientSHAP, DeepLIFTSHAP) using three increasingly complex synthetic Raman datasets with known ground truth signals. Results demonstrate SpecReX's superior ability to identify discriminating spectral features while providing more interpretable, less noisy explanations compared to traditional methods. This addresses a critical need for explainable AI in medical diagnostics where regulatory requirements demand transparent decision-making processes.

## Method Summary
SpecReX employs a recursive mutation approach to identify minimal sufficient spectral regions for classification. The algorithm generates random split coordinates to create "mutant" spectra where non-retained regions are occluded through linear interpolation with Gaussian noise. These mutants are queried against the target model, and if classification persists, the retained region is deemed "sufficient." The process recursively refines this region to find the smallest subset maintaining correct classification, effectively tracing the causal boundary of the decision. This contrasts with gradient-based methods by focusing on causal responsibility rather than sensitivity.

## Key Results
- On single peak dataset: SpecReX identified 2.2 and 1.78 peaks for classes 0 and 1 respectively, versus 276-285 peaks for SHAP variants
- On double peak dataset: SpecReX identified 22.62 and 5.46 peaks versus 279-282 peaks for SHAP variants
- On complex peak dataset: SpecReX identified 1.06 and 10.66 peaks versus 582-600 peaks for SHAP variants

## Why This Works (Mechanism)

### Mechanism 1
- **Claim:** SpecReX isolates discriminating spectral features by identifying the minimal subset of wavenumbers required to retain the original classification.
- **Mechanism:** The algorithm generates random split coordinates to create "mutant" spectra where non-retained regions are occluded. It queries the model with these mutants. If the classification persists, the retained region is deemed "sufficient." The algorithm recursively refines this region, searching for the smallest subset that still yields the correct classification, effectively tracing the causal boundary of the decision.
- **Core assumption:** The deep learning model's decision boundary is primarily dependent on local spectral features (peaks) rather than global statistical properties (e.g., total intensity), and these features can be decoupled via occlusion.
- **Evidence anchors:** [Page 4] Describes ReX using "causal responsibility" to build a map by iteratively refining occlusions and checking classification retention. [Page 5] Details the recursive refinement of mutants to isolate important regions. [Corpus] Paper 79792 notes that deep learning classifiers often outperform classical methods, but require robust explanation tools to verify they are not learning spurious artifacts.
- **Break condition:** If the model uses a distributed global representation (e.g., the entire spectral shape) rather than localized peaks, the minimal sufficient subset approach may fail to converge or return the entire spectrum.

### Mechanism 2
- **Claim:** Linear interpolation with Gaussian noise serves as a "neutral" occlusion that prevents the introduction of artifacts common in standard masking techniques.
- **Mechanism:** In image XAI, occlusion often involves zeroing pixels. In Raman spectroscopy, a zero-value region implies a saturated detector (a specific, distinct signal). SpecReX instead interpolates between the start and end points of the occluded region and adds noise. This mimics a featureless baseline, preventing the model from reacting to the occlusion mask itself.
- **Core assumption:** A linear interpolation with noise is perceptually equivalent to "no information" or a baseline signal to the underlying CNN/LSTM model.
- **Evidence anchors:** [Page 5] "SpecReX interpolates between the two endpoints of an occluded region, providing a plausible null region... devoid of Raman features, but also devoid of induced features, such as saturation." [Page 13] Mentions future work exploring non-linear interpolations and Poisson noise to better match physical reality. [Corpus] Paper 73167 highlights that Raman spectra suffer from "spectral noise" and "fluorescence background," validating the need for occlusion strategies that respect baseline physics.
- **Break condition:** If the baseline is highly non-linear (e.g., complex fluorescence background), a simple linear interpolation may register as an anomalous "dip" or feature to the model, confounding the explanation.

### Mechanism 3
- **Claim:** Bounded responsibility scores (0 to 1) reduce the noise in explanations compared to unbounded SHAP values, facilitating clinical interpretation.
- **Mechanism:** SpecReX assigns a normalized responsibility score to wavenumbers based on their frequency of appearance in successful minimal mutants. This contrasts with SHAP, which can assign arbitrarily high or low (negative) values. The normalization enforces a consistent scale across different samples, reducing the "salt-and-pepper" noise visible in gradient-based methods.
- **Core assumption:** The causal responsibility calculation accurately reflects the model's dependency logic, and "noise" in an explanation (irrelevant peaks highlighted) is primarily a failure of the explanation method rather than the model.
- **Evidence anchors:** [Page 12] "SpecReX has a set scale (responsibility values are always bounded between 0 and 1)... Conversely, SHAP values are unbounded... making it difficult to intuitively interpret." [Page 10, Figure 6] Visual evidence shows SHAP variants highlighting large swathes of the spectrum, while SpecReX localizes strictly to the ground truth peak. [Corpus] Paper 28118 discusses self-supervised learning for Raman to handle limited labels, but implicitly reinforces the difficulty of interpreting "black box" features without strict localization methods.
- **Break condition:** If multiple peaks contribute synergistically (non-additively) to a classification, a simple responsibility ranking might obscure the interaction effects between peaks.

## Foundational Learning

- **Concept: Raman Spectroscopy Signals**
  - **Why needed here:** You cannot debug the XAI outputs if you cannot distinguish a real Raman peak (signal) from a fluorescent baseline or detector saturation (noise).
  - **Quick check question:** If you see a sharp spike at 0 cm⁻¹ in a spectrum, is that a Raman peak or a Rayleigh scattering artifact? (Answer: It's likely Rayleigh scattering or saturation; Raman peaks are shifts relative to the incident light).

- **Concept: Actual Causality & Responsibility**
  - **Why needed here:** SpecReX is built on the formal logic of "actual causality" (Halpern & Pearl), not just gradient sensitivity. Understanding this distinction explains why it searches for *minimal* sets rather than *all* influential features.
  - **Quick check question:** If removing a peak changes the classification, does that prove the peak was *responsible* for the original classification, or just *sufficient* for the change? (Answer: Actual causality formalizes this counterfactual dependency).

- **Concept: 1D CNNs and LSTMs (LRCNs)**
  - **Why needed here:** The target model in the paper is a Long-term Recurrent Convolutional Network. You need to understand that the CNN extracts local spatial features (peaks) while the LSTM captures sequential dependencies (spectral shape/order).
  - **Quick check question:** Why might an LSTM be better for spectroscopy than a simple MLP? (Answer: It respects the sequential nature of the wavenumber axis, capturing correlations between adjacent peaks).

## Architecture Onboarding

- **Component map:** Input: 1D Spectral Vector -> Target Model (CNN + LSTM classifier) -> SpecReX Engine (Mutator -> Querier -> Aggregator) -> Output: Responsibility Map
- **Critical path:** The **Recursive Mutation Loop**. The algorithm creates a mutant, checks the class, and if correct, narrows the search space (sets start/end to the retained region) and repeats. If this recursion depth is too shallow, the explanation remains coarse. If the model accuracy is low (<80%), this loop may fail to find consistent retaining regions.
- **Design tradeoffs:**
  - **Interpolation vs. Zeroing:** The paper chooses interpolation to avoid "saturation" artifacts. *Tradeoff:* Linear interpolation is computationally cheaper but may be less realistic on curved baselines than the proposed future "non-linear" interpolation.
  - **Model Agnosticism:** SpecReX relies only on inference calls. *Tradeoff:* It is slower than gradient-based methods (like Integrated Gradients) because it requires many forward passes per spectrum.
- **Failure signatures:**
  - **"Smeared" Explanations:** If the responsibility map highlights the whole spectrum, the `max_search_tree_depth` may be insufficient, or the model is overfitted to global intensity.
  - **Baseline Artifacts:** If the explanation highlights the "valleys" between peaks, the linear interpolation is likely failing to match the baseline, causing the model to react to the shape of the occlusion itself.
- **First 3 experiments:**
  1. **Sanity Check (Single Peak):** Train a model on the "Single Peak" synthetic dataset. Run SpecReX. Verify it highlights *only* the 250 or 750 cm⁻¹ peak and ignores the "faux" peak.
  2. **Occlusion Ablation:** Run SpecReX on the same model using "Zero Occlusion" (masking with 0s) instead of interpolation. Compare the noise levels to validate the paper's claim about saturation artifacts.
  3. **Noise Robustness:** Increase the Gaussian noise scaling factor in the "Complex Peak" dataset. Observe at what noise level SpecReX explanations become unstable (error bars on peak count increase).

## Open Questions the Paper Calls Out

### Open Question 1
- Question: Does incorporating non-linear interpolation and Poisson noise into occlusion methods improve the accuracy of SpecReX explanations compared to the current linear interpolation with Gaussian noise?
- Basis in paper: [explicit] The authors state, "In future work, we will further exploit this ability by adding non-linear interpolations for occluded regions and adding Poisson noise... We can then assess whether these more realistic occlusions... lead to more accurate explanations."
- Why unresolved: The current implementation uses linear interpolation and Gaussian noise, which are mathematical simplifications that may not perfectly mimic the baseline variations and shot noise characteristics of real Raman spectra.
- What evidence would resolve it: A comparative study showing that SpecReX variants using Poisson noise and non-linear baselines identify ground truth peaks with higher fidelity in complex simulated or real datasets.

### Open Question 2
- Question: Can SpecReX maintain its fidelity in identifying ground truth signals when applied to complex biological data, specifically in vitro biomolecular mixtures and ex vivo oncology samples?
- Basis in paper: [explicit] The paper notes, "We will more thoroughly assess the validity of SpecReX by creating an in vitro ground truth... The following step will be to apply SpecReX to ex vivo RS data taken from clinically motivated oncology studies."
- Why unresolved: The tool has currently only been validated on idealized simulated datasets where the "ground truth" is mathematically seeded, leaving its performance on noisy, uncontrolled clinical data unproven.
- What evidence would resolve it: Successful identification of known biomarkers in controlled lab mixtures and histopathologist verification of discriminating features in ex vivo tissue samples.

### Open Question 3
- Question: Does the formal definition of "actual causality" provide a more useful explanation for clinical decision-making than the current responsibility map approach?
- Basis in paper: [explicit] The authors ask, "In future work we will explore whether this definition [minimal set of features based on actual causality] allows for more useful explanations from the perspective of clinical decision making."
- Why unresolved: While the paper demonstrates that SpecReX can locate features, it is unclear if the specific output format (responsibility maps vs. minimal sets) aligns with the cognitive workflow and regulatory needs of clinicians.
- What evidence would resolve it: User studies with clinicians comparing the utility of "minimal sufficient sets" versus dense responsibility maps for diagnosing disease states.

## Limitations
- Evaluation constrained to synthetic datasets with ground truth peaks, not real-world Raman spectra complexity
- Claim of bounded scores being "more interpretable" lacks empirical user validation with clinicians
- Computational cost comparisons missing, as SpecReX requires many model queries versus single-pass gradient methods

## Confidence
- **High confidence** in SpecReX's superior peak localization on synthetic data with known ground truth
- **Medium confidence** in the clinical interpretability advantage of bounded scores without empirical user validation
- **Medium confidence** in occlusion interpolation superiority without testing alternative occlusion strategies on real baselines

## Next Checks
1. Test SpecReX on real clinical Raman datasets (e.g., tissue classification) where ground truth peaks are unknown but diagnostic accuracy can be verified
2. Compare computational runtime and model query requirements against gradient-based XAI methods on identical hardware
3. Conduct a user study with domain experts comparing SpecReX versus SHAP explanations for clinical decision-making tasks